GlassScriptPhysician profile
Rohan A Joseph
NPI 1659649432
$14,213.51
in general payments reported to CMS, 2019-2025
38 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,130 · 2020: $11K · 2021: $430 · 2022: $415 · 2023: $301 · 2024: $592 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,097.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,094.99 | 2019-2023 | |
| Davol INC. | $384.26 | 2020-2025 | Phasix Mesh |
| Kerecis Limited | $302.65 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $136.35 | 2019-2024 | Collagenase Santyl, Stravix, Oasis |
| Ethicon US, LLC | $117.36 | 2019-2025 | Endopath Xcel |
| W. L. Gore & Associates, INC. | $115.14 | 2022 | |
| Asensus Surgical, INC. | $94.59 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $74.62 | 2022 | |
| Allergan, INC. | $72.40 | 2019 | |
| Medtronic, INC. | $68.28 | 2023-2024 | Progrip, Endo Clip III |
| Hologic Sales and Service, LLC | $66.84 | 2023-2025 | Coolseal Generator, Trunode |
| Focal Therapeutics, INC. | $46.12 | 2019-2020 | |
| Tela Bio, INC. | $44.60 | 2022 | |
| Merck Sharp & Dohme LLC | $44.09 | 2019 | |
| Molli Surgical (US) INC | $37.98 | 2024 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $36.51 | 2019-2024 | Integra, Omnigraft, Surgimend |
| Endo Pharmaceuticals INC. | $33.78 | 2019-2023 | Nascobal |
| Lsi Solutions INC | $33.00 | 2023 | Ti Knot, Running Device |
| Vertex Pharmaceuticals Incorporated | $30.92 | 2025 | |
| Organogenesis INC. | $30.72 | 2023 | Puraply |
| Acell, INC. | $29.66 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.22 | 2021 | |
| Cardinal Health 414 LLC | $25.85 | 2019 | |
| Olympus America INC. | $24.45 | 2019 | |
| Urgo Medical North America, LLC | $24.17 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Innocoll Pharmaceuticals Limited | $20.82 | 2021 | |
| Kci USA, INC. | $20.06 | 2023 | V.A.C.Instill |
| Novo Nordisk INC | $19.89 | 2023 | Wegovy |
| Teleflex LLC | $19.38 | 2025 | Titan Sgs Bailout Chuck |
| Covidien LP | $17.59 | 2020 | |
| Dilon Technologies, INC. | $16.42 | 2025 | Hemoblast Bellows |
| Misonix INC | $16.01 | 2019 | |
| Merit Medical Systems INC | $15.96 | 2021 | |
| Shire North American Group INC | $15.45 | 2019 | |
| Avanos Medical | $14.82 | 2019 | |
| Abbvie INC. | $14.63 | 2025 | |
| Boston Scientific Corporation | $13.37 | 2022 | |
| Alexion Pharmaceuticals, INC. | $11.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohan Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.